267 related articles for article (PubMed ID: 31614431)
1. Penfluridol as a Candidate of Drug Repurposing for Anticancer Agent.
Tuan NM; Lee CH
Molecules; 2019 Oct; 24(20):. PubMed ID: 31614431
[TBL] [Abstract][Full Text] [Related]
2. Analogs of penfluridol as chemotherapeutic agents with reduced central nervous system activity.
Ashraf-Uz-Zaman M; Sajib MS; Cucullo L; Mikelis CM; German NA
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3652-3657. PubMed ID: 30389290
[TBL] [Abstract][Full Text] [Related]
3. Penfluridol: An Antipsychotic Agent Suppresses Metastatic Tumor Growth in Triple-Negative Breast Cancer by Inhibiting Integrin Signaling Axis.
Ranjan A; Gupta P; Srivastava SK
Cancer Res; 2016 Feb; 76(4):877-90. PubMed ID: 26627008
[TBL] [Abstract][Full Text] [Related]
4. Anti-tumor effects of penfluridol through dysregulation of cholesterol homeostasis.
Wu L; Liu YY; Li ZX; Zhao Q; Wang X; Yu Y; Wang YY; Wang YQ; Luo F
Asian Pac J Cancer Prev; 2014; 15(1):489-94. PubMed ID: 24528079
[TBL] [Abstract][Full Text] [Related]
5. Repurposing antipsychotics of the diphenylbutylpiperidine class for cancer therapy.
Shaw V; Srivastava S; Srivastava SK
Semin Cancer Biol; 2021 Jan; 68():75-83. PubMed ID: 31618686
[TBL] [Abstract][Full Text] [Related]
6. Immune consequences of penfluridol treatment associated with inhibition of glioblastoma tumor growth.
Ranjan A; Wright S; Srivastava SK
Oncotarget; 2017 Jul; 8(29):47632-47641. PubMed ID: 28512255
[TBL] [Abstract][Full Text] [Related]
7. Penfluridol suppresses glioblastoma tumor growth by Akt-mediated inhibition of GLI1.
Ranjan A; Srivastava SK
Oncotarget; 2017 May; 8(20):32960-32976. PubMed ID: 28380428
[TBL] [Abstract][Full Text] [Related]
8. Targeting DRD2 by the antipsychotic drug, penfluridol, retards growth of renal cell carcinoma via inducing stemness inhibition and autophagy-mediated apoptosis.
Tung MC; Lin YW; Lee WJ; Wen YC; Liu YC; Chen JQ; Hsiao M; Yang YC; Chien MH
Cell Death Dis; 2022 Apr; 13(4):400. PubMed ID: 35461314
[TBL] [Abstract][Full Text] [Related]
9. The Antipsychotic Drug Penfluridol Inhibits N-Linked Glycoprotein Processing and Enhances T-cell-Mediated Tumor Immunity.
Xu W; Wang Y; Zhang N; Lin X; Zhu D; Shen C; Wang X; Li H; Xue J; Yu Q; Lu X; Zhou L; He Q; Tang Z; He S; Fan J; Pan J; Tang J; Jiang W; Ye M; Lu F; Li Z; Dang Y
Mol Cancer Ther; 2024 May; 23(5):648-661. PubMed ID: 37963566
[TBL] [Abstract][Full Text] [Related]
10. Cationic amphiphilic drugs as potential anticancer therapy for bladder cancer.
van der Horst G; van de Merbel AF; Ruigrok E; van der Mark MH; Ploeg E; Appelman L; Tvingsholm S; Jäätelä M; van Uhm J; Kruithof-de Julio M; Thalmann GN; Pelger RCM; Bangma CH; Boormans JL; van der Pluijm G; Zwarthoff EC
Mol Oncol; 2020 Dec; 14(12):3121-3134. PubMed ID: 32896947
[TBL] [Abstract][Full Text] [Related]
11. Penfluridol induces endoplasmic reticulum stress leading to autophagy in pancreatic cancer.
Ranjan A; German N; Mikelis C; Srivenugopal K; Srivastava SK
Tumour Biol; 2017 Jun; 39(6):1010428317705517. PubMed ID: 28618969
[TBL] [Abstract][Full Text] [Related]
12. Study of penfluridol and chlorpromazine in the treatment of chronic schizophrenia.
Wang RI; Larson C; Treul SJ
J Clin Pharmacol; 1982; 22(5-6):236-42. PubMed ID: 7107969
[TBL] [Abstract][Full Text] [Related]
13. Penfluridol for schizophrenia.
Soares BG; Lima MS
Cochrane Database Syst Rev; 2006 Apr; (2):CD002923. PubMed ID: 16625563
[TBL] [Abstract][Full Text] [Related]
14. Penfluridol: a long acting oral antipsychotic drug.
Claghorn JL; Mathew RJ; Mirabi M
J Clin Psychiatry; 1979 Feb; 40(2):107-9. PubMed ID: 368045
[TBL] [Abstract][Full Text] [Related]
15. Penfluridol: a long-acting oral neuroleptic. A controlled study.
Kurland AA; Ota KY; Slotnick VB
J Clin Pharmacol; 1975; 15(8-9):611-21. PubMed ID: 1097478
[TBL] [Abstract][Full Text] [Related]
16. Penfluridol suppresses pancreatic tumor growth by autophagy-mediated apoptosis.
Ranjan A; Srivastava SK
Sci Rep; 2016 May; 6():26165. PubMed ID: 27189859
[TBL] [Abstract][Full Text] [Related]
17. Penfluridol: a neuroleptic drug designed for long duration of action.
Migdalof BH; Grindel JM; Heykants JJ; Janssen PA
Drug Metab Rev; 1979; 9(2):281-99. PubMed ID: 385274
[TBL] [Abstract][Full Text] [Related]
18. A twelve month comparison of penfluridol and trifluoperazine in chronic schizophrenic outpatients.
Donlon PT; Meyer JE
J Clin Psychiatry; 1978 Jun; 39(6):582-3, 686-8. PubMed ID: 350861
[TBL] [Abstract][Full Text] [Related]
19. A long-term study of penfluridol in chronic schizophrenia.
Jus A; Pineau R; Jus K; Villeneuve A; Gautier J; Drolet A; Cote M
J Clin Pharmacol; 1976; 16(5-6):298-303. PubMed ID: 770513
[TBL] [Abstract][Full Text] [Related]
20. Penfluridol steady-state kinetics in psychiatric patients.
Cooper SF; Dugal R; Albert JM; Bertrand M
Clin Pharmacol Ther; 1975 Sep; 18(3):325-9. PubMed ID: 1100301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
